Researchers reported that those subjects with past cannabis exposure possessed slightly lower odds of AKI (OR 0.85) than did those with no exposure
22 percent affirmed having provided CBD to a child on the autism spectrum. Seventy-two percent of all respondents were parents while the remaining 28 percent were caregivers.
Middle-aged women are frequently acknowledging using cannabis to treat symptoms associated with menopause, according to survey data presented at the annual meeting of The North American Menopause Society.
Patients who consume CBD-dominant varieties of cannabis or cannabis products experience decreased levels of anxiety and depressive symptoms than do similarly matched controls, according to data published in the journal Frontiers in Psychiatry.
Cannabis exposure during adolescence is not independently associated with either adult-onset psychosis or signs of schizophrenia, according to longitudinal data published in the Journal of Abnormal Psychology.
Patients diagnosed with fibromyalgia and other inflammatory rheumatic diseases report experiencing reduced levels of pain and improved sleep quality following their use of medical cannabis products, according to data published in the journal Pain Research and Management.
The initiation of medical cannabis therapy is associated with a reduction in the use of prescription opioids by chronic pain patients, according to data published in the journal BMJ Supportive & Palliative Care.
A small but growing number of states now permit eligible patients to be reimbursed for their medical cannabis-related costs through their workers’ compensation insurance (WCI) plans, according to an analysis of state policies conducted by the National Institute for Occupational Safety and Health.
The administration of CBD is associated with short-term improvements in verbal recall in healthy subjects, according to randomized trial data published in the Journal of Psychiatric Research.
The use of various preparations of whole-plant cannabinoids is associated with perceived benefits among patients with the painful skin disease epidermolysis bullosa (EB), according to survey data published in the Orphanet Journal of Rare Diseases. Epidermolysis bullosa is a rare genetic condition that results in blistering skin.